Dr. Barbara Papadopoulou, B.Pharm., M.Sc., Ph.D., is a Professor in the Department of Microbiology-Infectious Disease and Immunology of the Laval University School of Medicine and the Director of the Axis of Infectious Diseases and Immunity of the CHU de Quebec Research Center-Laval University, since 2010. Her areas of expertise are parasitic diseases, regulation of gene expression, microbial pathogenesis, genomics, and vaccinology. Over the years, her laboratory has made remarkable discoveries on the molecular mechanisms controlling the intracellular development of the protozoan parasite Leishmania and on post-transcriptional regulation by novel classes of 3’UTR elements and RNA binding factors that have significantly advanced knowledge in this area. The fascinating concept of coordinated gene regulation by retroposons has revolutionized the landscape of gene expression control in this parasite. Her laboratory has also been a pioneer in the use of reverse genetics and genomics in Leishmania. She has also contributed to original work on the development of promising vaccine strategies against Leishmania infections. Her sustained efforts on vaccine development have led to patents and innovative live vaccine-based strategies that are currently being evaluated in relevant disease models in endemic countries. Dr. Papadopoulou is an internationally recognized leader in the field of Leishmania. She currently holds some very influential roles in international research networks (Leishmania Genome Network, TriTrypDB, The European Cooperation in the Field of Scientific and Technical Research COST B22) and in advisory expert committees (WorldLeish, World Health Organization) and she has established numerous collaborations, internationally. She has been actively involved, as member of the organizing scientific or local committees, in the organization of more than 8 international congresses on leishmaniasis and other parasitic diseases, and has also organized more than 15 symposia in this field.
Dr. Papadopoulou is the author of over 135 scientific publications and of several reviews and book chapters. She has received several prestigious national and international awards and distinctions for excellence in research, including the Burroughs Wellcome Fund Award in Molecular Parasitology for her outstanding contributions to the field of Leishmania research, and the nomination as Fellow of the Canadian Academy of Health Sciences, in 2013. Her leadership role as a woman in biomedical sciences has also been highlighted on several occasions (YWCA Women of Distinction Award Winner 2012, Science and Technology, 50 Successful Women from the Quebec City Region of Chaudière-Appalaches, ’22 Quebecers to watch’ by L’Actualité magazine, etc.). Dr. Papadopoulou is a member of several international consortia, as well as national (CIHR) and international (Burroughs Wellcome Fund Pathogenesis of Infectious Disease Program, Faculty of 1000 Biology, National Council for Scientific and Technological Development/Brazil, Hellenic Quality Assurance Agency for higher education, etc.) peer review and advisory committees. She is also an elected Faculty member of Greek Universities (APELLA). Until recently, she was until a member and Vice-Chairman of the Board of Directors of the Fonds de Recherche du Québec-Santé (FRQS) and the Board of Directors of the Canadian Academy of Health Sciences.
2705, boulevard Laurier
Canada G1V 4G2
Data not available
- Boilard, AlexandreInternalexandre.firstname.lastname@example.org
- Dumas, CaroleEmployeeCHUL+1 418-525-4444, extension 47639+1 email@example.com
2705, boulevard Laurier
Canada G1V 4G2
- Flahaut, Mathilde CannelleDoctoral studentCHUL+1 418-525-4444, extension firstname.lastname@example.org@ulaval.ca
2705 Boulevard Laurier
Canada G1V 4G2
- Reis Ferreira, GabrielDoctoral studentGabriel.Ferreira@crchudequebec.ulaval.ca
Altered expression of an RBP-associated arginine methyltransferase 7 in Leishmania major affects parasite infection.Journal Article
Mol Microbiol, 2014, ISSN: 0950-382X.
Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.Journal Article
Vaccine, 32 (43), pp. 5730-9, 2014, ISSN: 0264-410X.
Genome-wide stochastic adaptive DNA amplification at direct and inverted DNA repeats in the parasite Leishmania.Journal Article
PLoS Biol, 12 (5), pp. e1001868, 2014, ISSN: 1544-9173.
Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen.Journal Article
PLoS Negl Trop Dis, 8 (3), pp. e2751, 2014, ISSN: 1935-2727.
An Alba-domain protein contributes to the stage-regulated stability of amastin transcripts in Leishmania.Journal Article
Mol Microbiol, 91 (3), pp. 548-61, 2014, ISSN: 0950-382X.
Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice.Journal Article
Parasite Immunol, 35 (12), pp. 397-408, 2013, ISSN: 0141-9838.
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.Journal Article
PLoS Negl Trop Dis, 7 (4), pp. e2174, 2013, ISSN: 1935-2727.
Apoptosis-like programmed cell death induces antisense ribosomal RNA (rRNA) fragmentation and rRNA degradation in Leishmania.Journal Article
Cell Death Differ, 19 (12), pp. 1972-82, 2012, ISSN: 1350-9047.
Analysis of membrane-enriched and high molecular weight proteins in Leishmania infantum promastigotes and axenic amastigotes.Journal Article
J Proteome Res, 11 (8), pp. 3974-85, 2012, ISSN: 1535-3893.
Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species.Journal Article
Nucleic Acids Res, 40 (3), pp. 1131-47, 2012, ISSN: 0305-1048.
- Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
- Centre de recherche en infectiologie, Subvention, Institutionnel - BDR, BDR - Centres de recherche reconnus, from 1996-06-01 to 2024-11-06
- Post-transcriptional regulatory networks coordinating developmental gene expression in the human pathogen Leishmania, Subvention, Instituts de recherche en santé du Canada, Volet Projet: Concours pilotes, from 2016-07-01 to 2021-06-30
Recently finished projects
- 3.5 Impact of environmental conditions on airway microbiota and resratory health in the North, Subvention, Secrétariat des programmes interorganismes à l’intention des établissements, Fonds d'excellence en recherche Apogée Canada, from 2017-04-01 to 2020-03-31